Radionetics Oncology is a clinical-stage biotechnology company developing precision radiopharmaceutical treatments for cancer. The company designs small-molecule radioligands that target G-protein-coupled receptors (GPCRs) to selectively deliver targeted radiation therapy to solid tumors, including breast and lung cancer, combining GPCR biology… - View it on GitHub